tiprankstipranks
Trending News
More News >
Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
India Market

Kilitch Drugs (India) Limited (KILITCH) Financial Statements

Compare
0 Followers

Kilitch Drugs (India) Limited Financial Overview

Kilitch Drugs (India) Limited's market cap is currently ₹5.85B. The company's EPS TTM is ₹4.97; its P/E ratio is 19.95; Kilitch Drugs (India) Limited is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 1.98B₹ 1.54B₹ 1.40B₹ 1.14B₹ 681.28M
Gross Profit₹ 937.39M₹ 731.38M₹ 624.64M₹ 337.44M₹ 300.07M
Operating Income₹ 283.55M₹ 211.11M₹ 148.60M₹ 89.85M₹ 36.19M
EBITDA₹ 426.26M₹ 287.43M₹ 206.50M₹ 134.13M₹ 79.85M
Net Income₹ 267.01M₹ 146.01M₹ 104.48M₹ 73.67M₹ 36.71M
Balance Sheet
Cash & Short-Term Investments₹ 593.98M₹ 690.19M₹ 591.77M₹ 572.43M₹ 488.49M
Total Assets₹ 3.13B₹ 2.40B₹ 2.20B₹ 2.10B₹ 2.03B
Total Debt₹ 494.24M₹ 316.46M₹ 221.94M₹ 204.32M₹ 148.04M
Net Debt₹ 396.24M₹ 127.36M₹ 23.48M₹ 104.22M₹ 23.55M
Total Liabilities₹ 1.12B₹ 643.88M₹ 689.41M₹ 695.55M₹ 736.97M
Stockholders' Equity₹ 2.02B₹ 1.76B₹ 1.52B₹ 1.39B₹ 1.27B
Cash Flow
Free Cash Flow₹ -293.31M₹ -65.97M₹ -12.26M₹ -24.19M₹ 93.61M
Operating Cash Flow₹ 175.42M₹ -1.46M₹ 25.86M₹ 57.83M₹ 456.59M
Investing Cash Flow₹ -399.47M₹ -95.45M₹ 79.15M₹ -152.50M₹ -375.69M
Financing Cash Flow₹ 132.43M₹ 88.07M₹ -7.16M₹ 70.28M₹ 16.14M
Currency in INR

Kilitch Drugs (India) Limited Earnings and Revenue History

Kilitch Drugs (India) Limited Debt to Assets

Kilitch Drugs (India) Limited Cash Flow

Kilitch Drugs (India) Limited Forecast EPS vs Actual EPS